Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03801720 · ClinicalTrials.gov registry record · NA
UltraWee: Ultrasound Bladder Stimulation
A NA study, sponsored by State University of New York - Upstate Medical University.
- Terminated
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT03801720: Clinical Trial NA study, sponsored by State University of New York - Upstate Medical University.
NCT03801720 is a NA study that was terminated before completion, run by State University of New York - Upstate Medical University. The registered enrollment target is 4 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03801720, a NA study, was terminated before completion, sponsored by State University of New York - Upstate Medical University.
- TERMINATED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
The UltraWee study is a prospective randomized controlled trial used to compare the success rate of and time to obtaining a urine sample in pre-continent children between standard clean catch urine (CCU) method and using ultrasound stimulation clean catch methods. The objectives of this study are to see if ultrasound stimulation increases success rate of micturition, decreases time to micturition, and decreases the use of more invasive techniques for urine collection.
Primary Outcome
Recorded act of successfully initiating miturition/urination
Interventions
- OTHER Ultrasound
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2019-01-29 |
| Est. Completion | 2023-04-13 |
| Phase | NA |
Why NCT03801720 stopped before completion
NCT03801720 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Ultrasound is the first listed.
NCT03801720 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03801720 about?
NCT03801720 is a clinical study titled "UltraWee: Ultrasound Bladder Stimulation". The UltraWee study is a prospective randomized controlled trial used to compare the success rate of and time to obtaining a urine sample in pre-continent children between standard clean catch urine (CCU) method and using ultrasound stimulation clean catch methods. The objectives of this study are to...
What is the current status of trial NCT03801720?
This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2019-01-29. Estimated completion is 2023-04-13.
What interventions are being tested in trial NCT03801720?
The interventions under investigation include: Ultrasound (OTHER).
Who is sponsoring clinical trial NCT03801720?
This trial is sponsored by State University of New York - Upstate Medical University, which has 113 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03801720's enrollment target sits among peer trials
4 1996th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI